Navigation Links
GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
Date:11/15/2007

ATLANTA, Nov. 15 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company (the "Company"), today announced its financial results and provided an operational update for the quarter ended September 30, 2007.

Financial Results for the Quarter Ended September 30, 2007

The Company recorded a net loss of $1,165,509 for the three months ended September 30, 2007, compared to $283,434 for the same period in 2006. For the nine months ended September 30, 2007, the Company's net loss was $3,085,926 as compared to $426,890 in 2006. The increase in the net loss during 2007 is attributable to (a) no grant revenues recorded during the first nine months 2007, (b) higher research and development expenses as the Company continued to support its four ongoing Phase I human AIDS vaccine clinical trials and prepares for initiation of Phase II trials, (c) overall higher general and administrative expenses primarily due to the additional costs associated with being a public company subsequent to the merger between Dauphin Technology, Inc. and GeoVax, Inc. in September 2006., and (d) $928,302 of share-based compensation expense recorded in 2007, compared with $- 0 - for 2006. As of September 30, 2007, the Company reported cash balances totaling $731,976.

See the summarized financial information attached. Further information concerning the Company's financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

Recent Operational Highlights:

-- In July, GeoVax announced an early start of two new HIV/AIDS vaccine

clinical (human) trials. These FDA compliant trials were previously

scheduled to start later in 2007 and are the 3rd and 4th in a four

clinical trial series intended to evaluate both human safety and immune

responses to GeoVax's HIV/AIDS vaccines. Starting April 2006, the 1st'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. Biopure Announces 2007 Third Quarter Financial Results
5. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
6. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
7. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
8. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
9. Pharmacopeia Announces Third Quarter 2007 Financial Results
10. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
11. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  TNI BioTech, Inc. ... company focused on the development, marketing and distribution ... filed definitive proxy materials with the Securities and ... Meeting of Shareholders to be held on Thursday, ... Time. The record date for determining those shareholders ...
(Date:7/28/2014)... ANGELES , SINGAPORE, and TOKYO , ... announced that it has appointed Roger Crystal , ... most recently served in the Global Business Development Product ... "Roger,s experience in developing business strategy and ... valuable as we continue to partner with biotechnology and ...
(Date:7/28/2014)... 28, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... its second quarter 2014 financial results for the period ended ... close. PDL,s management will host a conference call and webcast ... financial results.  A slide presentation relating to the call will ... Conference Call Details To access the live ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2
... SYDNEY, Australia, June 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; ... Limited to,manage and provide eligible patients worldwide with ... The program will allow patients who are unable ... are considered by their physician,to be suffering from ...
... Claims Cover Anti-Viral Applications of Novel Targeted Agents Under ... Company,s Anti-Phospholipid Technology Platform -, - Anti-Viral ... Presented at American Association of Immunologists Annual Meeting ... (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company developing ...
Cached Medicine Technology:Pharmaxis Establishes Named Patient Program for Bronchitol 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4
(Date:7/28/2014)... Dawn Echols’ professional background spans success in ... experience has honed her people skills and led ... counseling ( http://dawningphoenix.com ) work includes private practice, ... domestic violence. , As owner and executive ... individuals and groups for a variety of disorders. ...
(Date:7/28/2014)... 2014 (HealthDay News) -- Elementary school students seem to be ... according to a new study of school officials. , , ... Agriculture -- went into effect in the fall of 2012. ... buying lunch, or throw away most of their food. But ... this isn,t the case. , , "The updated meals standards ...
(Date:7/28/2014)... 28, 2014 Ticket Down is ... tickets in Dallas, TX at the Cotton Bowl. The ... the USA and it is an eight team tourney. ... world including teams from La Liga, Serie A, English Premier ... battle it out on the pitch include: Manchester United, ...
(Date:7/28/2014)... 28, 2014 Shofner Vision Center ... June . Renowned LASIK and Cataract Surgeon, Dr. ... significant funds and public awareness for local not-for-profit ... personnel and their families. “This was our 2nd ... nearly $5,000 to a variety of local not-for-profit ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cape ... Summit Provider Exchange technology solution in an ... efforts and support collaboration with their New Jersey ... acute-care medical center located in New Jersey, serves ... visitors with a variety of inpatient and outpatient ...
Breaking Medicine News(10 mins):Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 2Health News:Real Madrid vs. AS Roma Tickets Cotton Bowl Dallas, TX: Ticket Down Cuts Ticket Prices for AS Roma vs. Real Madrid International Champions Cup Tickets 3Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3
... 24 For the second,consecutive year, the Ohio ... help fund dental education in Ohio., Supporting ... ODAF,funded five grants and 25 scholarships in September. ... students and 11 to dental auxiliary,students., Recipients ...
... one guy and one gal to,be selected as the ,hot ... Sept. 24 If you,ve ever been to Joe,Weider,s Olympia ... Vegas. With,the help of The Vitamin Shoppe and BodyTech.com it,s ... for two participants to,realize their dream of being a star ...
... HTH Worldwide, a global health,and safety services company, ... serve as Chief Financial Officer. Mr. Joseph joins ... company continue its history of strong and,profitable growth. ... Finance and,Accounting at Neoware, Inc., King of Prussia, ...
... 24 The Tri-Council for,Nursing is collaborating with ... study of the impact Advanced Practice Registered Nurses,(APRNs) ... first,comprehensive study of its kind in 20 years, ... by nurses in the four APRN roles --,Clinical ...
... nationwide study to explore an investigational treatment for advanced ... Trial focuses on airway bypass, a minimally invasive procedure ... breath typical complications of emphysema - by making ... , During the airway bypass procedure, new ...
... Barack,Obama and John McCain arrive in Oxford, Mississippi for ... activists from across the,country demanding that the next president ... in office., On Friday, September 26, at 3 ... will hold a demonstration and mock funeral at Oxford ...
Cached Medicine News:Health News:Ohio Dental Association Foundation Again Awards Over $60,000 in Dental Education Grants and Scholarships Across Ohio 2Health News:Who Will Be The 'Hot Bod' at the Olympia? 2Health News:HTH Worldwide Welcomes New Chief Financial Officer 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 2Health News:27 National Nursing Organizations Join Together to Commission a Study of the Impact of Advanced Practice Registered Nurses on Healthcare Quality, Safety, and Effectiveness 3Health News:Potential treatment option for severe emphysema under study 2Health News:AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy 2
... , Combined Advanced Technologies, The ... technologically advanced combination of high pressure ... Proprietary coextrusion process yields a remarkably ... conventional high pressure balloon materials., Non-Compliant ...
Used retrograde to dilate the ureter and establish a conduit for a flexible ureteroscope. Supplied sterile in peel-open packages. Intended for one-time use....
... Diameter; 5.4 Fr Straight Channel; 33 or ... MRO-7 Integral Operating Ureteroscopes offer a small ... easy access to the ureter for diagnosis ... Fr) is ideal for large operating instruments, ...
... self-dilating, semi-rigid autoclavable operating ureteroscope featuring distortion-free ... for an enhanced, clear image. The universal ... diopters. The direction of view is 5 ... straight access operating channel is ideal for ...
Medicine Products: